Dying to Survive
The story of how a small drugstore owner became the exclusive selling agent of a cheap Indian generic drug against Chronic Granulocytic Leukemia in China.
Rollout
Domestic (–)
–
–
International (100%)
$451,176,639
$451,176,639
Worldwide
$451,176,639
$451,176,639
| China | |||
|---|---|---|---|
| Market | Release Date | Opening | Gross |
| China | Jul 5, 2018 | $152,163,428 | $451,176,639 |
